ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AGN Argenica Therapeutics Limited

0.785
0.015 (1.95%)
31 May 2024 - Closed
Delayed by 20 minutes

Income Statement

Balance Sheet

Cash Flow

Year End 30 June 2023 20202020202120222023
AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)
Total Revenue 00296k259k1.75M
Operating Income -383k0-614k-4.09M-4.88M
Pre Tax Income -383k0-1.03M-4.09M-4.82M
Net Income -383k0-1.03M-4.09M-4.82M
Preferred Dividends 00000
Basic Earnings Per Share (EPS) -0.0150-0.014-0.047-0.049
EBIT -383k0-614k-4.09M-4.88M
EBITDA -383k0-614k-4.09M-4.88M